dc.contributor.authors |
Vatan, Mehmet Bulent; Cakmak, Ahmet Can; Agac, Suret; Eynel, Emre; Erkan, Hakan |
|
dc.date.accessioned |
2022-12-20T13:25:07Z |
|
dc.date.available |
2022-12-20T13:25:07Z |
|
dc.date.issued |
2022 |
|
dc.identifier.issn |
0003-3197 |
|
dc.identifier.uri |
http://dx.doi.org/10.1177/00033197221106886 |
|
dc.identifier.uri |
https://hdl.handle.net/20.500.12619/99199 |
|
dc.description |
Bu yayının lisans anlaşması koşulları tam metin açık erişimine izin vermemektedir. |
|
dc.description.abstract |
In this study, we aimed to evaluate the utility of the immune-inflammation index (SII) in estimating the no-reflow phenomenon and short-term cardiovascular prognosis in patients with ST-segment elevation myocardial infarction (STEMI). 723 consecutive patients with STEMI who underwent primary percutaneous coronary intervention (PCI) were enrolled in our study. The receiver-operating characteristics (ROC) curve was used to determine the cut-off value of SII to predict the no-reflow. The multivariate regression analysis analyzed the correlation between no-reflow and SII. The median value of SII was significantly higher in patients with no-reflow in comparison with normal reperfusion [1466 (939-2409) vs 905 (566-1379), p < .001]. The optimal threshold for SII in predicting the no-reflow phenomenon was 1036, with sensitivity and specificity of 70% and 59%, respectively. The area under the ROC curve (AUC) was 0.71 (95% CI, 0.66-0.75, p < .001). In multivariate analysis, SII >= 1036 value showed an independent predictive value for the no-reflow (OR = 0.51, 95% CI: 0.29-0.92, p = .02) and the 30-day cardiovascular mortality (OR = 2.37, 95% CI: 1.34-4.19, p = .003). Our results suggest that higher SII levels are independently associated with the no-reflow phenomenon and 30-day mortality in STEMI patients undergoing primary PCI. |
|
dc.language |
English |
|
dc.language.iso |
eng |
|
dc.relation.isversionof |
10.1177/00033197221106886 |
|
dc.subject |
Cardiovascular System & Cardiology |
|
dc.subject |
cardiovascular outcome |
|
dc.subject |
myocardial reperfusion |
|
dc.subject |
ST segment elevation myocardial infarction |
|
dc.title |
The Systemic Immune-Inflammation Index Predicts Impaired Myocardial Perfusion and Short-Term Mortality in ST-Segment Elevation Myocardial Infarction Patients |
|
dc.type |
Early Access |
|
dc.contributor.authorID |
VATAN, MEHMET BULENT/0000-0002-5259-8441 |
|
dc.relation.journal |
ANGIOLOGY |
|
dc.identifier.doi |
10.1177/00033197221106886 |
|
dc.identifier.eissn |
1940-1574 |
|
dc.contributor.author |
Vatan, Mehmet Bulent |
|
dc.contributor.author |
Cakmak, Ahmet Can |
|
dc.contributor.author |
Agac, Suret |
|
dc.contributor.author |
Eynel, Emre |
|
dc.contributor.author |
Erkan, Hakan |
|
dc.relation.publicationcategory |
Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı |
|